Business Description
Australian Clinical Labs Ltd
ISIN : AU0000148496
Description
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.84 | |||||
| Debt-to-EBITDA | 1.81 | |||||
| Interest Coverage | 14.68 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.55 | |||||
| Beneish M-Score | -3.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 54.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | -0.31 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.75 | |||||
| 9-Day RSI | 45.71 | |||||
| 14-Day RSI | 43.17 | |||||
| 6-1 Month Momentum % | -21.21 | |||||
| 12-1 Month Momentum % | -20.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.62 | |||||
| Quick Ratio | 0.54 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 50.89 | |||||
| Days Sales Outstanding | 34.66 | |||||
| Days Payable | 81.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.95 | |||||
| Dividend Payout Ratio | 2.69 | |||||
| Forward Dividend Yield % | 4.95 | |||||
| 5-Year Yield-on-Cost % | 4.95 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 7.38 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.78 | |||||
| Operating Margin % | 7.51 | |||||
| Net Margin % | 5.19 | |||||
| ROE % | 18.58 | |||||
| ROA % | 5.98 | |||||
| ROIC % | 6.17 | |||||
| ROC (Joel Greenblatt) % | 17.01 | |||||
| ROCE % | 12.99 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.98 | |||||
| Forward PE Ratio | 14.9 | |||||
| PE Ratio without NRI | 15.98 | |||||
| PS Ratio | 0.84 | |||||
| PB Ratio | 3.35 | |||||
| Price-to-Tangible-Book | 71.5 | |||||
| Price-to-Free-Cash-Flow | 4.2 | |||||
| Price-to-Operating-Cash-Flow | 4.01 | |||||
| EV-to-EBIT | 16.73 | |||||
| EV-to-Forward-EBIT | 11.24 | |||||
| EV-to-EBITDA | 4.97 | |||||
| EV-to-Forward-EBITDA | 4.45 | |||||
| EV-to-Revenue | 1.26 | |||||
| EV-to-Forward-Revenue | 1.27 | |||||
| EV-to-FCF | 6.31 | |||||
| Price-to-Graham-Number | 7.53 | |||||
| Earnings Yield (Greenblatt) % | 5.98 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Australian Clinical Labs Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 692.103 | ||
| EPS (TTM) (A$) | 0.179 | ||
| Beta | 0 | ||
| Volatility % | 33.74 | ||
| 14-Day RSI | 43.17 | ||
| 14-Day ATR (A$) | 0.088548 | ||
| 20-Day SMA (A$) | 2.913 | ||
| 12-1 Month Momentum % | -20.78 | ||
| 52-Week Range (A$) | 2.7 - 3.87 | ||
| Shares Outstanding (Mil) | 201.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Australian Clinical Labs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Australian Clinical Labs Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Australian Clinical Labs Ltd Frequently Asked Questions
What is Australian Clinical Labs Ltd(ASX:ACL)'s stock price today?
The current price of ASX:ACL is A$2.83. The 52 week high of ASX:ACL is A$3.87 and 52 week low is A$2.70.
When is next earnings date of Australian Clinical Labs Ltd(ASX:ACL)?
The next earnings date of Australian Clinical Labs Ltd(ASX:ACL) is 2024-02-29 Est..
Does Australian Clinical Labs Ltd(ASX:ACL) pay dividends? If so, how much?
The Dividend Yield %  of Australian Clinical Labs Ltd(ASX:ACL) is 4.95% (As of Today), Highest Dividend Payout Ratio of Australian Clinical Labs Ltd(ASX:ACL) was 2.69. The lowest was 0.14. And the median was 1.41. The  Forward Dividend Yield % of Australian Clinical Labs Ltd(ASX:ACL) is 4.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers